Artikkeleita

A Special Year for the Biotech Sector

Kemia-Kemi Vol. 40 (2013) 5

Carmela Kantor-Aaltonen

Introduction

In many ways, the biotech sector in Finland has had a remarkable 2013. It has been a year of enforcement of the biobank law, trading licenses for Finnish drugs, and new strategies for the health care sector and bioeconomy.

pdfDownload article PDF

The Future Generation of Bioscientists - Lost or Found?

Kemia-Kemi Vol. 39 (2012) 5

Carmela Kantor-Aaltonen

Introduction

The level of bioscience education in Finnish universities is high, but the employment rate of bioscientists is worrying. The students need transferable skills to advance their employment, and the biotechnology sector needs governmental support to create jobs and develop into a blooming industry sector.

pdf Download article 2 pages, PDF

Yritysrahoitteinen tutkimus yliopistossa

IPR Info 5/2011 ja 1/2012

Klaus Nyblin ja Charlotta Henriksson

Johdanto

Biolääketieteen yliopistotutkimukseen liittyy monia erityispiirteitä. Artikkelissa käsitellään tutkimusyhteistyösopimuksia sekä sopimusoikeuden että kilpailuoikeuden näkökulmasta ja korkeakoulukeksintölain soveltamista yritysten rahoittamissa tutkimushankkeissa. Lisäksi akatemiaprofessori Kari Alitalo kommentoi artikkelissa yliopistotutkimusta tutkijan näkökulmasta. Professori Alitalo johtaa Helsingin yliopistossa Biomedicumissa Suomen Akatemian huippuyksikköä ja sen yhteydessä toimivaa syövän biologian (Molecular Cancer Biology) tieteellistä tutkimusohjelmaa.

pdf Lataa artikkeli IPR Info 5/2011, s. 19-20

pdf Lataa artikkeli IPR Info 1/2012, s. 17-18

IPR University Center - Immateriaalioikeusinstituutti - www.iprinfo.com

Culminatum works to develop an attractive innovation environment for biotechnology in the BSR

Baltic Rim Economies (2011) 5

Pekka Ihalmo

Introduction

Culminatum Innovation Ltd was established in 1995 to serve as a joint regional development instrument for its owners and to implement the national Centre of Expertise programme in the Helsinki region. Due to its triple-helix ownership structure, Culminatum represents a unique, independent platform able, on the one hand, to respond rapidly to the demands of local business clusters and cities and, on the other hand, to address future challenges facing society, e.g. in the healthcare sector. Since Culminatum’s founding, biotechnology and life sciences have been one key focus area in developing the Helsinki area towards sustainable economy.

pdf Download article 1 page, PDF (30 KB)

New Horizons For the Bioindustry

Kemia-Kemi Vol. 38 (2011) 5

Carmela Kantor-Aaltonen

Introduction

Bioeconomy could bring new companies and business opportunities to the biotech sector in Finland, but it requires clarification of the ambiguous concept and collaboration between different industry sectors.

pdf Lataa artikkeli 2 sivua, PDF (400 KB)